|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6592877B1
(en)
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
BR9909472A
(pt)
|
1998-04-07 |
2001-09-11 |
Corixa Corp |
Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
|
|
ES2333073T3
(es)
*
|
1998-11-04 |
2010-02-16 |
Isis Innovation Limited |
Prueba diagnostica de tuberculosis.
|
|
US6555115B1
(en)
|
1998-12-08 |
2003-04-29 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6432916B1
(en)
|
1998-12-08 |
2002-08-13 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US20020061848A1
(en)
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6448234B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6565856B1
(en)
*
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6447779B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds for the diagnosis of Chlamydial infection
|
|
US20030027774A1
(en)
*
|
1999-03-18 |
2003-02-06 |
Ronald C. Hendrickson |
Tuberculosis antigens and methods of use therefor
|
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
EP1229931A4
(en)
*
|
1999-10-07 |
2003-05-28 |
Corixa Corp |
FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS
|
|
US7009042B1
(en)
|
1999-10-07 |
2006-03-07 |
Corixa Corporation |
Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
|
|
ES2282142T3
(es)
*
|
1999-10-07 |
2007-10-16 |
Corixa Corporation |
Una secuencia de micobacterium tuberculosis para la expresion de proteinas heterologas.
|
|
US6316205B1
(en)
|
2000-01-28 |
2001-11-13 |
Genelabs Diagnostics Pte Ltd. |
Assay devices and methods of analyte detection
|
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
GB0006692D0
(en)
*
|
2000-03-20 |
2000-05-10 |
Glaxo Group Ltd |
Epitopes
|
|
US6919187B2
(en)
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
AU2001255596A1
(en)
|
2000-04-21 |
2001-11-07 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
DE60139963D1
(de)
|
2000-06-20 |
2009-10-29 |
Corixa Corp |
Fusionsproteine aus mycobakterium tuberculosis
|
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US6841159B2
(en)
|
2002-01-30 |
2005-01-11 |
The United States Of America As Represented By The Secretary Of The Navy |
Rapid lateral flow assay for determining exposure to Mycobacterium tuberculosis and other mycobacteria
|
|
US7026465B2
(en)
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
WO2005061534A2
(en)
*
|
2003-12-23 |
2005-07-07 |
Statens Serum Institut |
Improved tuberculosis vaccines
|
|
CN101103045B
(zh)
|
2004-09-24 |
2015-11-25 |
安姆根有限公司 |
修饰的Fc分子
|
|
US8475735B2
(en)
|
2004-11-01 |
2013-07-02 |
Uma Mahesh Babu |
Disposable immunodiagnostic test system
|
|
EA012037B1
(ru)
|
2004-11-16 |
2009-06-30 |
Круселл Холланд Б.В. |
Поливалентные вакцины, содержащие рекомбинантные вирусные векторы
|
|
CN100368437C
(zh)
*
|
2005-01-28 |
2008-02-13 |
中国农业科学院哈尔滨兽医研究所 |
一种诊断牛结核病的重组抗原蛋白及其制备方法
|
|
KR20130110233A
(ko)
|
2005-04-29 |
2013-10-08 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
결핵균 감염을 예방 또는 치료하기 위한 신규한 방법
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
CN100999550B
(zh)
*
|
2006-01-10 |
2010-10-06 |
中国人民解放军第三○九医院 |
结核分枝杆菌融合蛋白及其应用
|
|
CN101311190B
(zh)
*
|
2006-06-06 |
2011-08-03 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN101298471B
(zh)
*
|
2006-06-06 |
2011-01-19 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN101311189B
(zh)
*
|
2006-06-06 |
2010-09-08 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN100415771C
(zh)
*
|
2006-06-06 |
2008-09-03 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
AU2007264205B2
(en)
*
|
2006-06-28 |
2013-04-18 |
Statens Serum Institut |
Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
HUE036180T2
(hu)
|
2006-09-26 |
2018-06-28 |
Infectious Disease Res Inst |
Szintetikus adjuvánst tartalmazó vakcina készítmény
|
|
EP2433648A3
(en)
|
2006-10-12 |
2012-04-04 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
|
PT2086582E
(pt)
|
2006-10-12 |
2013-01-25 |
Glaxosmithkline Biolog Sa |
Vacina compreendendo uma emulsão adjuvante óleo em água
|
|
US9717788B2
(en)
|
2007-03-02 |
2017-08-01 |
Glaxosmithkline Biologicals Sa |
Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
|
|
HUE031411T2
(en)
|
2007-03-02 |
2017-07-28 |
Glaxosmithkline Biologicals Sa |
New Methods and Preparations
|
|
BRPI0809926B8
(pt)
|
2007-04-04 |
2021-05-25 |
Infectious Disease Res Inst |
composição que compreende antígenos de mycobacterium tuberculosis, polipeptídeo de fusão isolado, polinucleotídeo isolado que codifica o dito polipeptídeo e uso da dita composição para estimular uma resposta imune protetora
|
|
US7732580B2
(en)
*
|
2007-10-13 |
2010-06-08 |
Cornell University |
Compositions for eliciting an immune response against Mycobacterium avium subspecies paratuberculosis
|
|
KR101378240B1
(ko)
|
2008-02-22 |
2014-03-28 |
포항공과대학교 산학협력단 |
결핵 예방용 조성물
|
|
US8518410B2
(en)
|
2009-03-10 |
2013-08-27 |
Baylor Research Institute |
Fusion protein with HIV antigen
|
|
PT2315834T
(pt)
|
2008-07-25 |
2018-08-10 |
Glaxosmithkline Biologicals Sa |
A proteína rv2386c de tuberculose, composições e as suas utilizações
|
|
SI2315773T1
(sl)
*
|
2008-07-25 |
2016-12-30 |
Glaxosmithkline Biologicals S.A. |
Polipeptidi, polinukleotidi in sestavki za uporabo pri zdravljenju latentne tuberkuloze
|
|
LT2315597T
(lt)
|
2008-07-25 |
2018-02-12 |
Glaxosmithkline Biologicals S.A. |
Naujos kompozicijos ir būdai
|
|
GB0815872D0
(en)
|
2008-09-01 |
2008-10-08 |
Pasteur Institut |
Novel method and compositions
|
|
US9562104B2
(en)
|
2009-03-10 |
2017-02-07 |
Baylor Research Institute |
Anti-CD40 antibodies
|
|
JP5986382B2
(ja)
|
2009-03-10 |
2016-09-06 |
ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ |
抗原提示細胞ターゲティング癌ワクチン
|
|
HUE031051T2
(en)
|
2009-06-05 |
2017-06-28 |
Infectious Disease Res Inst |
Synthetic glycopyranosyl lipid adjuvant and vaccine compositions containing it
|
|
HRP20161608T1
(hr)
|
2010-01-27 |
2017-01-13 |
Glaxosmithkline Biologicals Sa |
Modificirani tuberkulozni antigeni
|
|
US20130195961A1
(en)
|
2010-03-09 |
2013-08-01 |
Kejian Yang |
Novel mucosal vaccination approach for herpes simplex virus type-2
|
|
CA2819297A1
(en)
|
2010-12-14 |
2012-06-21 |
Glaxosmithkline Biologicals S.A. |
Mycobacterium antigenic composition
|
|
GB201022007D0
(en)
|
2010-12-24 |
2011-02-02 |
Imp Innovations Ltd |
DNA-sensor
|
|
CN102154324B
(zh)
*
|
2010-12-29 |
2012-11-28 |
兰州大学 |
结核分枝杆菌融合蛋白Mtb10.4-Hsp16.3的构建、表达和纯化方法及其应用
|
|
EP2688592A4
(en)
|
2011-03-25 |
2015-07-22 |
Baylor Res Inst |
Compositions and methods for immunization against the hepatitis C virus
|
|
EP3632463A1
(en)
|
2011-04-08 |
2020-04-08 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
US20120288515A1
(en)
|
2011-04-27 |
2012-11-15 |
Immune Design Corp. |
Synthetic long peptide (slp)-based vaccines
|
|
CN102305855A
(zh)
*
|
2011-05-19 |
2012-01-04 |
中山大学 |
体外检测结核分枝杆菌感染的试剂和方法
|
|
WO2013063059A1
(en)
*
|
2011-10-24 |
2013-05-02 |
University Of Central Florida Research Foundation, Inc. |
Plastid-expressed mycobacterium tuberculosis vaccine antigens esat-6 and mtb72f fused to cholera toxin b subunit
|
|
WO2013119856A1
(en)
|
2012-02-07 |
2013-08-15 |
Infectious Disease Research Institute |
Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
|
|
MX347154B
(es)
|
2012-02-24 |
2017-02-21 |
Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) |
Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
|
|
SI2850431T1
(en)
|
2012-05-16 |
2018-08-31 |
Immune Design Corp. |
Vaccines for hsv-2
|
|
CN102757971B
(zh)
*
|
2012-08-07 |
2013-09-11 |
中国人民解放军第三O九医院 |
一种结核分枝杆菌重组蛋白质及其制备方法
|
|
EP2912056B1
(en)
|
2012-10-23 |
2020-02-12 |
Statens Serum Institut |
M. tuberculosis vaccines
|
|
DK2941269T3
(da)
|
2013-01-07 |
2021-01-11 |
Mucosal Vaccine Tech Llc |
Terapeutiske vacciner til behandling af herpes simplex-virus type 2-infektioner
|
|
JP2016516075A
(ja)
*
|
2013-03-15 |
2016-06-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
結核の予防または治療用の合成免疫原
|
|
EP2986303B1
(en)
|
2013-04-18 |
2020-02-26 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
IL246456B2
(en)
|
2013-12-31 |
2024-06-01 |
Access To Advanced Health Inst |
Formulations will be assembled into a single vial
|
|
EP3094652B1
(en)
|
2014-01-13 |
2021-09-29 |
Baylor Research Institute |
Novel vaccines against hpv and hpv-related diseases
|
|
US20190062400A1
(en)
*
|
2016-03-02 |
2019-02-28 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
WO2017176076A1
(en)
|
2016-04-06 |
2017-10-12 |
Ewha University - Industry Collaboration Foundation |
A peptide with ability to penetrate cell membrane
|
|
MX2018014086A
(es)
|
2016-05-16 |
2019-09-18 |
Infectious Disease Res Inst |
Formulacion que contiene agonista tlr y metodos de uso.
|
|
BR112018073676B1
(pt)
|
2016-05-16 |
2023-10-03 |
University Of Virginia Patent Foundation |
Lipossomas peguilados e métodos de uso
|
|
CA3023271A1
(en)
|
2016-06-01 |
2017-12-07 |
Infectious Disease Research Institute |
Nanoalum particles containing a sizing agent
|
|
US11141377B2
(en)
|
2017-06-15 |
2021-10-12 |
Infectious Disease Research Institute |
Nanostructured lipid carriers and stable emulsions and uses thereof
|
|
CA3078223A1
(en)
|
2017-09-08 |
2019-03-14 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
|
US10610585B2
(en)
|
2017-09-26 |
2020-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating and preventing HIV
|
|
CN109825497A
(zh)
*
|
2019-01-25 |
2019-05-31 |
石河子大学 |
一种新型结核杆菌融合菌株的制备方法及其应用
|
|
WO2020243115A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
EP4583841A1
(en)
|
2022-09-09 |
2025-07-16 |
Access to Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|
|
CN118652311B
(zh)
*
|
2024-07-17 |
2025-02-25 |
扬州大学 |
结核分枝杆菌复合体ⅶ型分泌系统效应蛋白cfp10保守功能性b细胞表位及其应用
|